These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14648450)

  • 1. Obstacles to the development of prevention and public health policies in Argentina.
    Touzé G
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S372-5. PubMed ID: 14648450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug use, harm reduction, and health policies in Argentina: obstacles and new perspectives.
    Inchaurraga S
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S366-71. PubMed ID: 14648449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harm reduction actions as a health care construction process at a public health center in Rosario, Argentina.
    Lavarello D; Lottero M; Chavero M; Toledo A; Espínola M; Gerlero S; Liborio M
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S353-7. PubMed ID: 14648446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulnerable among the vulnerable: drug users in situations of poverty and indigence in Argentina.
    Vivas LE; Radulich G; Bruno D
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S358-61. PubMed ID: 14648447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus/acquired immunodeficiency syndrome prevention in injection drug users and their partners and children: lessons learned in Latin America--the Argentinean case.
    Rossi D; Goltzman P; Cymerman P; Touzé G; Weissenbacher M
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S362-5. PubMed ID: 14648448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors.
    De La Fuente L; Bravo MJ; Barrio G; Parras F; Suárez M; Rodés A; Noguer I
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S410-5. PubMed ID: 14648456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brazilian response to the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among injection drug users.
    Mesquita F; Doneda D; Gandolfi D; Nemes MI; Andrade T; Bueno R; Piconez e Trigueiros D
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S382-5. PubMed ID: 14648452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus prevention and the potential of drug abuse treatment.
    Metzger DS; Navaline H
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S451-6. PubMed ID: 14648463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
    Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
    Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of implementation of preventive programs in a developing country: experiences, situations, and perspectives in Uruguay.
    Osimani ML
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S422-6. PubMed ID: 14648458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of HIV/AIDS among injection drug users: the theory and science of public health and criminal justice approaches to disease prevention.
    Gostin LO; Lazzarini Z
    Emory Law J; 1997; 46(2):587-696. PubMed ID: 11769762
    [No Abstract]   [Full Text] [Related]  

  • 13. Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: a regional overview.
    Bobrova N; Sarang A; Stuikyte R; Lezhentsev K
    Int J Drug Policy; 2007 Aug; 18(4):313-8. PubMed ID: 17689380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/AIDS: Latin America & Caribbean. Argentina: up in smoke: epidemic changes course.
    Cohen J
    Science; 2006 Jul; 313(5786):487-8. PubMed ID: 16873656
    [No Abstract]   [Full Text] [Related]  

  • 15. Human immunodeficiency virus and the substance abuser: public policy considerations.
    Ruiz P; Fernandez F
    Tex Med; 1994 May; 90(5):64-7. PubMed ID: 8029770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV/AIDS: a minority health issue.
    Cargill VA; Stone VE
    Med Clin North Am; 2005 Jul; 89(4):895-912. PubMed ID: 15925655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Needle syringe acquisition and HIV prevention among injecting drug users: a treatise on the "good" and "not so good" public health practices in South Asia.
    Panda S; Sharma M
    Subst Use Misuse; 2006; 41(6-7):953-77. PubMed ID: 16809181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
    Emmanuel F; Fatima M
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention, control and treatment of HIV-AIDS among injecting drug use in Bandung, Indonesia.
    Alisjahbana B; Susanto H; Roesli R; Yusuf H; Hinduan Z; Mase JC; Surahman E; van der Ven A
    Acta Med Indones; 2009 Jul; 41 Suppl 1():65-9. PubMed ID: 19920301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Providers' HIV prevention discussions with HIV-seropositive injection drug users.
    Wilkinson JD; Zhao W; Santibanez S; Arnsten J; Knowlton A; Gómez CA; Metsch LR;
    AIDS Behav; 2006 Nov; 10(6):699-705. PubMed ID: 16639542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.